Ceftriaxone 2g Every 12 Hours is Preferred Over a Single 2-Hour Infusion
For serious bacterial infections requiring ceftriaxone, administer 2g every 12 hours rather than a single 2g dose given over 2 hours. The divided dosing regimen provides superior pharmacodynamic coverage and is the standard recommended by multiple clinical guidelines.
Guideline-Based Dosing Recommendations
The UK Joint Specialist Societies guideline 1 consistently recommends ceftriaxone 2g IV every 12 hours as the preferred empirical regimen for serious infections including:
- Meningitis (both meningococcal and pneumococcal): 2g every 12 hours 1
- Meningococcal sepsis: 2g every 12 hours 1
- Haemophilus influenzae infections: 2g every 12 hours 1
- Enterobacteriaceae infections: 2g every 12 hours 1
The American Heart Association guideline for infective endocarditis 2 similarly recommends ceftriaxone 100 mg/kg/day divided every 12 hours (or 80 mg/kg/day every 24 hours if over 2g total, divide BID), supporting twice-daily dosing for serious infections.
Pharmacokinetic and Pharmacodynamic Evidence
Why Divided Dosing is Superior:
Beta-lactam antibiotics like ceftriaxone exhibit time-dependent killing, meaning efficacy depends on maintaining drug concentrations above the minimum inhibitory concentration (MIC) for the maximum duration of the dosing interval 3.
The FDA label data 3 demonstrates that:
- After a 2g IV dose, plasma concentrations peak at 257 mcg/mL but decline to 115 mcg/mL by 24 hours
- The elimination half-life ranges from 5.8-8.7 hours
- Multiple dosing at 12-24 hour intervals results in 15-36% drug accumulation
Recent pharmacokinetic studies strongly favor divided dosing:
A 2024 murine pneumonia model 4 demonstrated that 2g once-daily was significantly more effective than 1g twice-daily against S. pneumoniae with MICs ≤2 mg/L. However, this compared total daily doses of 2g vs 2g split—not a single dose vs divided dosing of the same total amount.
More critically, a 2026 pharmacokinetic study in sepsis patients 5 found that standard 2g every 24 hours was only adequate for pathogens with MIC ≤1 mg/L. At higher MICs, target attainment decreased significantly, particularly in patients with GFR >130 mL/min, with twice-daily dosing yielding higher drug exposures.
A 2026 Indonesian study 6 concluded that once-daily regimens failed to achieve optimal efficacy targets in patients with preserved or augmented renal function (eGFR ≥60 mL/min/1.73 m²), recommending 1g every 12 hours for these patients.
Clinical Outcomes Data:
A 2025 prospective cohort study 7 comparing 1g every 12 hours vs 2g every 24 hours in community-acquired pneumonia found no significant difference in treatment failure or mortality, but noted a trend toward fewer side effects with divided dosing (1.04% vs 4.20%, p=0.08).
A 1995 randomized controlled trial 8 demonstrated equivalent efficacy between cefotaxime 2g every 12 hours and ceftriaxone 2g once daily, with clinical success rates of 86.3% vs 90.4% respectively—supporting that divided dosing of ceftriaxone would be at least equivalent.
Practical Dosing Algorithm
For adults with serious bacterial infections:
Standard dosing: Ceftriaxone 2g IV every 12 hours 1
Adjust based on renal function 6:
- eGFR >60 mL/min/1.73 m²: 1-2g every 12 hours
- eGFR ≤60 mL/min/1.73 m²: 1-2g every 24 hours may be adequate
- No dose adjustment needed for mild-moderate renal impairment 3
Consider pathogen MIC:
Infusion duration: Administer over 30 minutes (standard), not as a 2-hour infusion 3
Critical Caveats
A single 2-hour infusion is not a recognized dosing strategy in any guideline or FDA labeling. The question appears to conflate infusion duration with dosing frequency.
Once-daily dosing (2g every 24 hours) is acceptable for specific indications like uncomplicated infections with highly susceptible organisms, but divided dosing provides better coverage for serious infections 1, 5, 6.
Avoid once-daily dosing in: patients with augmented renal clearance, infections with higher MIC pathogens (>1 mg/L), or critically ill patients 5, 6.
The long half-life of ceftriaxone (5.8-8.7 hours) 3 allows once-daily dosing in some scenarios, but this advantage diminishes in serious infections requiring maximal time above MIC.